Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation | Zendy

Keitaro Senoo | Zendy; Gregory Y.H. Lip | Zendy; Deirdre A. Lane | Zendy; Harry R. Büller | Zendy; Dipak Kotecha | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation

Author(s) -

Keitaro Senoo,

Gregory Y.H. Lip,

Deirdre A. Lane,

Harry R. Büller,

Dipak Kotecha

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.009487

Subject(s) - medicine , atrial fibrillation , hazard ratio , stroke (engine) , interquartile range , heart failure , cardiology , warfarin , acenocoumarol , cohort , confidence interval , mechanical engineering , engineering

Atrial fibrillation (AF) and heart failure frequently coexist and are associated with increased morbidity and mortality. We investigated the prognosis of anticoagulated patients with permanent AF and nonpermanent AF according to preexisting heart failure in the AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research